VC-backed Zymeworks files for U.S. and Canadian IPO

Vancouver-based biotherapeutics company Zymeworks Inc has filed for a U.S. and Canadian IPO. The IPO, which will give the company a listing on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol “ZYME”, has not been officially priced; however, the U.S. Securities and Exchange Commission notes a proposed offering size of as much as $75 million. Zymeworks' backers include BDC Capital and Lumira Capital.

DealsNorth AmericaUSBriefs